Related Experiment Video
Updated: Jan 3, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.1K
Bridging the Efficacy-Effectiveness Gap in HIV Programs: Lessons From Economics.
Jacob Bor1, Harsha Thirumurthy2
1Department of Global Health, Boston University, Boston, MA.
Journal of Acquired Immune Deficiency Syndromes (1999)
|November 26, 2019
Summary
Understanding human behavior is key to closing the HIV prevention and treatment gap. Behavioral economics offers insights to improve HIV interventions worldwide.
Area of Science:
- Public Health
- Health Economics
- Behavioral Science
Background:
- The gap between HIV prevention/treatment efficacy and real-world effectiveness necessitates policies considering human behavior.
- Global HIV strategies must integrate behavioral insights for improved outcomes.
Purpose of the Study:
- To review the literature on HIV within the field of economics.
- To identify common themes and lessons for implementation science in HIV.
- To explore how behavioral economics can enhance HIV interventions.
Main Methods:
- Narrative literature review.
- Analysis of HIV research at the intersection of economics and behavioral science.
- Identification of themes related to decision-making and intervention effectiveness.
Main Results:
- Behavior is influenced by perceived costs/benefits across health and non-health domains.
- Structural constraints significantly shape decision-making processes.
- Information interventions remain effective in the ongoing HIV epidemic.
- Behavioral economics principles can optimize HIV intervention strategies.
Conclusions:
- Economic theories and empirical methods offer valuable guidance for HIV implementation science.
- Integrating behavioral economics can bridge the efficacy-effectiveness gap in HIV prevention and treatment.
- Policy development should prioritize understanding and leveraging human behavior in HIV response.
Related Concept Videos
01:10Retrovirus Life Cycles
49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
01:22Dose-Response Relationship: Potency and Efficacy
6.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.2K
01:26Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
01:21Causality in Epidemiology
1.4K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.4K
01:29Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
362
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
362